CPT1A and obesity disorder: In states of obesity or insulin resistance, alterations in the expression or activity of CPT1 and CPT2 may disrupt normal lipid metabolism, leading to reduced ATP production, mitochondrial dysfunction, and an increased susceptibility to cellular stress and apoptosis [77,78,79].